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INTRODUCTION
Studies on the molecular control of endothelial cell (EC)
morphogenesis during angiogenesis or vasculogenesis have
revealed many insights into how blood vessels participate in
complex biological processes such as development, wound
repair and tumorigenesis (Hanahan, 1997; Carmeliet and Jain,
2000; Yancopoulos et al., 2000; Conway et al., 2001).
Although considerable work has been performed identifying
factors that promote or inhibit angiogenic responses (Folkman,
1997; Carmeliet and Jain, 2000; Yancopoulos et al., 2000;
Conway et al., 2001), considerably less effort has focused on
how individual and groups of ECs assemble into capillary tubes
during these events. Identifying new molecular targets that
block specific steps in EC morphogenesis may become crucial
in efforts to inhibit angiogenesis in human diseases where
angiogenesis is a pathogenic component (i.e. cancer, diabetic
retinopathy, arthritis, atherosclerosis) (Folkman, 1995;
Carmeliet and Jain, 2000). 
One experimental approach to address these questions has
been to use in vitro models of EC morphogenesis where many
of the steps observed in vivo can be mimicked (Montesano et
al., 1992; Vernon and Sage, 1995; Nicosia and Villaschi, 1999).
The most promising assays for elucidating relevant molecules
and pathways necessary for EC morphogenesis are those using
3D extracellular matrices (ECM) composed of collagen type I
or fibrin (Montesano and Orci, 1985; Nicosia and Ottinetti,
1990; Davis and Camarillo, 1996; Ilan et al., 1998; Vernon and
Sage, 1999; Yang et al., 1999; Bayless et al., 2000; Davis et al.,
2000). These matrices represent the major matrix environments
where angiogenic or vasculogenic events take place (Vernon
and Sage, 1995; Senger, 1996; Nicosia and Villaschi, 1999). In
some of these assays, particularly where ECs are suspended as
individual cells in 3D matrices, most of the ECs undergo
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We have performed a screening analysis of differential gene
expression using a defined in vitro model of human
capillary tube formation. Gene array, differential display
and cDNA library screening were used to identify both
known and novel differentially expressed genes. Major
findings include: the upregulation and functional
importance of genes associated with basement membrane
matrix assembly; the upregulation of growth factors,
transcription factors, anti-apoptotic factors, markers of
endothelial cell differentiation, JAK-STAT signalling
molecules, adhesion receptors, proteinase inhibitors and
actin regulatory proteins; and expression changes
consistent with inhibition of cell cycle progression,
increased cholesterol biosynthesis, decreased ubiquitin-
proteasome mediated degradation, and activation of G-
protein signaling pathways. Using DNA microarray
analysis, the most induced genes at 8, 24 and 48 hours
compared with those at 0 hours were jagged-1,
stanniocalcin and angiopoietin-2, whereas the most
repressed genes were connective tissue growth factor,
fibulin-3 and RGS-5. In addition, the full length coding
sequence of two novel regulated capillary morphogenesis
genes (CMGs) are presented. CMG-1 encodes a predicted
intracellular 65 kDa protein with coiled-coil domains. A
CMG-1-green fluorescent protein (GFP) chimera was
observed to target to an intracellular vesicular
compartment. A second novel gene, CMG-2, was found to
encode a predicted intracellular protein of 45 kDa
containing a transmembrane segment and a CMG-2-GFP
chimera was observed to target to the endoplasmic
reticulum. A recombinant portion of CMG-2 was found to
bind collagen type IV and laminin, suggesting a potential
role in basement membrane matrix synthesis and assembly.
These data further elucidate the genetic events regulating
capillary tube formation in a 3D matrix environment. 
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morphogenesis simultaneously, which allows for an analysis of
differential gene expression in large numbers of ECs. This is a
critical aspect of EC morphogenic or regression microassays
developed by our laboratory (Davis and Camarillo, 1996;
Bayless et al., 2000; Davis et al., 2000; Davis et al., 2001). In
these systems, differential gene expression can be directly
correlated with distinct events in the EC morphogenic or
regression cascade (Salazar et al., 1999; Davis et al., 2001). 
Many studies over the years have shown that differential gene
expression controls complex biological phenomena (Brown and
Botstein, 1999). Recently, the development of gene array
technology has revealed how classes of differentially regulated
genes control processes such as yeast responses to glucose
deprivation, fibroblast responses to serum mitogens and tumor
development and apoptosis (DeRisi et al., 1997; Iyer et al., 1999;
Perou et al., 2000; Maxwell and Davis, 2000). These approaches
have been useful to characterize the role of previously identified
genes in a given process. To identify relevant differentially
expressed novel genes, additional techniques were developed
including differential display, subtraction cDNA cloning and
serial analysis of gene expression (SAGE) (Velculescu et al.,
1995; Martin and Pardee, 1999). Using this latter technology,
differentially regulated genes (known and novel) were identified
in colon carcinoma-derived endothelium versus normal colonic
endothelium (St. Croix et al., 2000).
Here, we present data using a number of the above
technologies to investigate differential gene expression during
human capillary morphogenesis in 3D collagen matrices.
Using gene array analysis, differential display and cDNA
library screening, hundreds of differentially expressed genes
have been identified. We have examined the expression
patterns of thousands of genes and have observed variable
modes of gene upregulation as well as gene downregulation
during a 48 hour time course of this process. In addition, the
full length sequence of two new genes is presented. This survey
analysis of differential gene expression serves as a basis for
future studies concerning the molecular regulation of capillary
morphogenesis in 3D extracellular matrices. 
MATERIALS AND METHODS
The GFP-N2 vector was from Clontech, while the pAdEasy
adenoviral system was kindly provided by Bert Vogelstein and Tong-
Chuan He (Johns Hopkins School of Medicine, Baltimore, MD). A
monoclonal antibody directed to hsp47 (Cates et al., 1987) was the
kind gift of B.D. Sanwal (University of Western Ontario, London,
Canada). Oligonucleotide primers were synthesized by Sigma-
Genosys (The Woodlands, TX). The pQE30 vector and Ni/Cd-
sepharose were from Qiagen (Valencia, CA). Antibodies to laminin
were obtained from Sigma (St Louis, MO), anti-Id1 was from Upstate
Biotechnologies (Lake Placid, NY), anti-collagen type IV from
Chemicon (Temecula, CA) and anti- a 2 macroglobulin from ICN
(Costa Mesa, CA). Peroxidase-conjugated rabbit anti-mouse IgG and
goat anti-rabbit IgG antibodies were from Dako (Carpinteria, CA) and
chemiluminescence reagents were from Amersham (Piscataway, NJ).
Rhodamine-conjugated rabbit anti-mouse IgG and fluorescein-
conjugated goat anti-rabbit IgG were from Dako. 
Capillary morphogenesis assay
Human umbilical vein endothelial cells (Clonetics, San Diego, CA)
were cultured as described (Maciag et al., 1979). EC cultures in 3D
collagen matrices were performed as described (Davis and Camarillo,
1996; Salazar et al., 1999) except that ECs (passages 2-5) were seeded
at 2 · 106 cells per ml of gel. 
DNA microarray analysis
DNA microarray analysis (DeRisi et al., 1997; Iyer et al., 1999) was
used to study genomic-scale gene expression comparing four time
points during capillary morphogenesis. Total RNA was extracted
(Chomczynski and Sacchi, 1987) from ECs in the collagen gel, after
collagenase treatment, using TRIzol reagent (Life Technologies, Grand
Island, NY) at 0, 8, 24 and 48 hour time points. Approximately 360
gels for each time point were needed to obtain enough mRNA for this
experiment. Total RNA was passed twice through Oligotex beads to
obtain mRNA (Qiagen). The poly-A RNA was eluted in DEPC-H2O
and sent to Incyte Genomics (St Louis, MO), who performed the
differential hybridization to a Unigem V chip containing 7,075 genes
comparing 0 hour with 8 hour, 24 hour and 48 hour RNA samples. The
data presented are ratios of hybridization between these time points.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was used to create cDNA templates and was equalized
between the time points by spectrophotometry and formaldehyde
agarose gel electrophoresis. Total RNA (5 m g) was used for reverse
transcription (Stratagene, La Jolla, CA) to create random-primed
cDNA at 0, 8, 24 and 48 hours of culture progression. RT-PCR
amplification parameters used were typically 94°C for 45 seconds,
60°C for 45 seconds, 72°C for 2 minutes; this was cycled 25 to 35
times, depending upon the gene, with a final extension at 72°C for 5
minutes using an PTC-100 thermal cycler (MJ Research, Watertown,
MA). Primer sequences are shown in Table 1.
Northern and western blot analyses
Northern blot analyses were performed using total RNA equalized by
spectrophotometry (3 m g per lane) from 0, 8, 24 and 48 hour time
points as described (Salazar et al., 1999). Collagen gels were removed
from wells, placed directly into boiling SDS sample buffer and heated
to 100°C for 10 minutes, and stored at - 20°C until use. Cell extracts
were run on standard SDS-PAGE gels or 7% Blattler SDS-PAGE gels
(collagen IV, laminin) (Blattler et al., 1972), and blots were incubated
and developed as described previously (Salazar et al., 1999). 
Differential display analysis
Differential display protocols (GenHunter, Nashville, TN) were used
to identify genes that are differentially regulated during capillary
morphogenesis (Liang and Pardee, 1998; Martin and Pardee, 1999).
A cDNA copy of the total RNA was created using random primers
from 0, 8, 24 and 48 hour time points. This cDNA amplification was
performed using combinations of three downstream oligo dT primers,
G-T11M, C-T11M and A-T11M, and a series of random 10 mer
upstream primers, AP-1 to AP-80 (ten sets of eight). We used sets one
and two of the random upstream primers (AP-1 to AP-16) in
combination with oligo dT downstream primers (GenHunter), which
represent about 20% of the total primer combinations. Forty cycles of
amplification, incorporating [g -33P]-dCTP, was used to create the
random fragments. The fragments were then run on a 6%
polyacrylamide sequencing gel using 1 · TAE as the running buffer,
and resolved by autoradiography. Differentially expressed bands were
excised, boiled to extract DNA, and ethanol precipitated using
glycogen as a carrier. Individual fragments were then amplified using
the appropriate differential display primers appropriate for that band
and purified for further use. DNA fragments were TA cloned into
pGEM-T-Easy (Promega, Madison, WI) and sequenced by automated
sequencing (Lonestar Laboratories, Houston, TX). 
Endothelial cell morphogenic cDNA libraries
cDNA libraries were made using mRNA isolated from 8 and 24 hour
cultures. Library production required 1 mg of total RNA isolated from
13 ml of collagen gel containing 2 · 106 cells/ml, which was aliquoted
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into 25 m l aliquots in 96-well A/2 microplates. After poly-A selection,
first- and second-strand cDNA synthesis was performed with oligo dT
primers. The cDNA was fractionated by size, and mass cloned into
the ZAP-XR vector using the Uni-Zap XR Stratagene system. The
cloning was performed unidirectionally, based on opposing EcoRI and
XhoI restriction sites at the 5 ¢ and 3¢ ends, respectively. Each fraction
was then packaged, and the first fraction was used for amplification
while the remaining fractions were left unamplified using standard
methodologies from Stratagene. These libraries were screened using
using 32P-labelled partial cDNAs to obtain larger clones (Wahl and
Berger, 1987).
Construction of recombinant adenoviruses
Recombinant adenoviral constructs were prepared essentially as
described (He et al., 1998). Full length CMG-1 and CMG-2 were cloned
into the GFP-N2 vector (Clontech) and were then amplified as GFP
fusion protein constructs and then further cloned into the pAdShuttle-
CMV vector. CMG-1 and CMG-2 were amplified and cloned into
pEGFP-N2 (Clontech) using XhoI and BamHI and XhoI and EcoRI
restriction sites, respectively. The following primer sets were used to
amplify CMG-1 or CMG-2 inserts: CMG-1 5¢ -AGCTCGAGACAAT-
GGCCAGCAATCAC-3¢ ; 5¢ -AGGGATCCGGTTTCCGCTGGTGCT-
ATG-3¢ . CMG-2 5¢ -AGCTCGAGAGGATGGTGGCGGAGCGGT-3¢ ;
5¢ -AGGAATTCAGCAGTTAGCTCTTTCTC-3¢ .
For cloning of these cDNAs into the pShuttle-CMV vector, BglII-
XbaI and XhoI-XbaI were used for CMG-1 and CMG-2, respectively.
The common downstream primer 5 ¢ -AGTCTAGATTATGATCTA-
GAGTCGCGGC-3 ¢ was used with the upstream primer 5 ¢ -
AGAGATCTACAATGGCCAGCAATCAC-3 ¢ for CMG-1 and 5 ¢ -
AGCTCGAGAGGATGGTGGCGGAGCGGT-3¢ for CMG-2. These
pShuttle-CMV clones were then recombined with pAdEasy-1 and
transfected into 293 cells to produce recombinant viruses. The viruses
were then amplified through three passages in 293 cells before use.
Extracts of 293 cells infected with these viruses were tested on SDS-
PAGE gels and western blots with anti-GFP antibodies, showing that
the fusion proteins had a molecular weight indicative of intact CMG-
1-GFP and CMG-2-GFP fusion proteins. Endothelial cell monolayers
were infected on gelatin-coated coverslips for 4-5 hours in serum-free
media and then this media was replaced with complete growth
media overnight. After 24 hours, cultures were fixed with 3%
paraformaldehyde and were either directly examined by fluorescence
microscopy or processed further for immunofluorescence staining as
described (Salazar et al., 1999).
Recombinant CMG-2 production and extracellular matrix
protein binding assays
A portion of recombinant CMG-2 (residues 34-214) was produced in
E. coli as a recombinant His-tagged protein. A CMG-2 cDNA was
Table 1. Primer sequences used for RT-PCR
Gene Upstream primer Downstream primer
Jagged-1 5 ¢ -TTCTCACTCGGGCATGATC-3 ¢ 5¢ -TTACAGCTGCCTCTGTTGTG-3¢
Stanniocalcin 5¢ -TCCACATCTTCACTCAAGCC-3 ¢ 5¢ -CCTTTGGAAAGTGGAGCAC-3 ¢
Egr-1 5¢ -TGAAGCTTCAGCAGTCCCATTTACTCAG-3 ¢ 5¢ -TGAAGCTTGACTGGTAGCTGGTATTG-3¢
Sprouty 5¢ -AACAGTGTGGGAAGTGCAAG-3 ¢ 5¢ -GCTGAAGATCATCCATGAGG-3 ¢
Myosin I-C 5 ¢ -TGGGAAGCAAAGGTGTCTAC-3 ¢ 5¢ -CACCACTGATAATGACGCAC-3¢
Angiopoietin-2 5 ¢ -ACTGTTCTTCCCACTGCAATC-3¢ 5¢ -TATCATCACAGCCGTCTGG-3 ¢
Id-1 5¢ -CGACATGAACGGCTGTTAC-3 ¢ 5¢ -GACACAAGATGCGATCGTC-3¢
CTGF 5¢ -TTCCAAGACCTGTGGGATG-3 ¢ 5¢ -ATGCCATGTCTCCGTACATC-3¢
RGS5 5¢ -AGTTGGGAATTCTCCTCCAG-3¢ 5¢ -AGCTGCTGTGGGAAGATATG-3 ¢
Fibulin-3 5¢ -ACATTGTCCCAGACGCTTG-3¢ 5¢ -GCAATATGGAGGGATGGTAC-3 ¢
a 2-Macroglobulin 5 ¢ -AGTCTTCATCCAATGAGGAGG-3 ¢ 5¢ -CAAATGCTCACAGTCACATGTC-3 ¢
Caveolin-1 5¢ -CGGAGTTTTCATCCAGCCAC-3¢ 5¢ -TGGCACCAGGAAAATTAAAAG-3¢
p16/ INK4A 5 ¢ -ACCCTCACATCAAGCGAAAC-3¢ 5¢ -GGAGTGAACGCATCGACTG-3¢
a 1 integrin 5 ¢ -TATTCTTCCACCGAAGAGGTAC-3¢ 5¢ -TCCATTTCAAATGAAGCTGC-3 ¢
a 2 integrin 5 ¢ -CGGATCCCCTGATTTTCAGCTCTCAGCC-3 ¢ 5¢ -ATGCTGAAAATTTGTTCTCC-3 ¢
a 3 integrin 5 ¢ -GGACTGGTGCTGTGTACCTG-3 ¢ 5¢ -TTGGTCCTCTGGGTCCTTA-3 ¢
a 5 integrin 5 ¢ -TTCAGTGGTGATGACACAGAAG-3 ¢ 5¢ -GTCAAGGAGCTGCCAAATC-3 ¢
a 6 integrin 5 ¢ -CACGTCAGAAAGCAAGGAAG-3 ¢ 5¢ -CTCAGGGAGGAGATGTGCAG-3 ¢
a v integrin 5 ¢ -CCCGGATGTTTCTTCTCG-3 ¢ 5¢ -TGAAATCTCCGACAGCCAC-3¢
a 1 integrin 5 ¢ -TACCCCAGCCGGTCCAACCTGA-3¢ 5¢ -ATGAATTATCATTAAAAGCTTC-3 ¢
a 3 integrin 5 ¢ -GCTGTGACCTGAAGGAGAATC-3 ¢ 5¢ -GTGACACACTCTGCTTCTTCAC-3¢
a 5 integrin 5 ¢ -AGATTGCCGTGAACCTCC-3 ¢ 5¢ -TCCATCCAATGCGATGTG-3¢
Collagen IV a 1 chain 5¢ -CCTGGCTTGAAAGGTGATAAG-3 ¢ 5¢ -CCCGCTATCCCTTGATCTC-3 ¢
Collagen IV a 2 chain 5¢ -TACATCAGCCGCTGTTCTG-3 ¢ 5¢ -TTTGGTTGGCACCTGAGG-3 ¢
Laminin a 4 chain 5¢ -TTGATGCCGTACTCTGCTG-3 ¢ 5¢ -CTGGGTCTTCTCCGTCAGTAG-3¢
Laminin a 5 chain 5¢ -CGCATCAGCTTCGACAGTC-3¢ 5¢ -TTGAGGTCCACATACTTGCC-3¢
Laminin b 1 chain 5¢ -TTTCAAGACATTCCGTCCAG-3 ¢ 5¢ -CCTCCACTTCTTCATTGAATC-3 ¢
Laminin g 1 chain 5¢ -ACTCTTAATCGCCTGAACAC-3 ¢ 5¢ -CTTAGAGAGCCCACAGGACTAC-3 ¢
Perlecan 5 ¢ -ACTCGGGCCAGTACATCTG-3 ¢ 5¢ -CACAGCACAGTGGAACTCAAC-3¢
Nidogen 5¢ -GACATCGACGCAGTCTACG-3 ¢ 5¢ -TTTCCTTCTTTGAGAATGTCG-3 ¢
Fibronectin 5 ¢ -CAACATTGATCGCCCTAAAG-3¢ 5¢ -CAACCACGGATGAGCTGTC-3 ¢
SPARC 5 ¢ -ACTGTGGCAGAGGTGACTG-3¢ 5¢ -GGCGCTTCTCATTCTCATG-3¢
Thrombospondin-1 5¢ -ATCGAGGATGCCAACCTG-3¢ 5¢ -AGGGCTGGAACCATTCAC-3 ¢
Thrombospondin-2 5¢ -CTTCGTGCGCTTTGACTAC-3¢ 5¢ -CCTTTGGCCACGTACATC-3¢
CMG1 (upstream) 5 ¢ -GCCAGCAATCACAAATCTTC-3 ¢ 5¢ -CGCTTGTCTTTCAGTAAATATG-3 ¢
CMG1 (downstream) 5¢ -GGCTGGTAATCACTCTTGAC-3 ¢ 5¢ -TTTGACTTTCAGACATTCAACG-3 ¢
CMG2 5 ¢ -TCCTGCAGAAGAGCCTTG-3¢ 5¢ -TGCATATGATGGCACCAAG-3¢
Fte-1 5¢ -AGGGAGCCAAGAAGAAAGTG-3 ¢ 5¢ -ATCGGTAGTCTTGACATCAAC-3 ¢
NADH Ubiq. Oxid. 5 ¢ -GGATTTGCTGCATTTGTG-3 ¢ 5¢ -TGTAAGGGATAAACCAGAC-3 ¢
Prothymosin-a 5¢ -CCGAAATCACCACCAAGG-3 ¢ 5¢ -CATCCTCGTCGGTCTTCTG-3¢
Melanin conc. horm. 5¢ -CATCAAACTAAGAATGGCAAAG-3 ¢ 5¢ -CCAACAGGGTCGGTACACTC-3¢
FGF-2 5 ¢ -ACTCCGGCCTCTATGCTTG-3¢ 5¢ - TCCACAATGCAGGTGTAGTTG-3¢
TFPI-2 5¢ -TTGGACTCTGGCATACCTAAC-3 ¢ 5¢ -GGAAGATTGAGCTGGAGTTC-3 ¢
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unidirectionally cloned into pQE30 through BamHI and HindIII sites.
Primers used to amplify CMG-2 were: 5 ¢ -AGGGATCCCAGG-
AGCAGCCCTCCTGC-3 ¢ ; 5¢ -AGAAGCTTAGAAGAATTAATTAT-
TCC-3¢ . The recombinant protein was purified using Ni/Cd-sepharose
as described (Bayless and Davis, 2001) and approximately 3 mg of
protein was obtained from 400 ml of IPTG-induced bacteria. Control
GFP was produced as a His-tagged protein and purified in the same
way. Both proteins were adsorbed to plastic microwells at 10 m g/ml
and, after detergent blocking (0.1% Tween-Tris-saline, pH 7.5) for 30
minutes, biotinylated extracellular matrix proteins were added (1
m g/ml) in 0.1% Tween-Tris-saline containing 1% BSA for 1 hour. The
biotinylated matrix proteins were prepared as described (Davis and
Camarillo, 1993). After washing, the wells were further incubated
with avidin-peroxidase at 1 m g/ml for 30 minutes in Tween-Tris-
saline-BSA and, after washing, were developed for peroxidase activity
and read at 490 nm. 
RESULTS
DNA microarray analysis of differential gene
expression during capillary morphogenesis in 3D
collagen matrices
To determine patterns of gene expression during EC
morphogenesis and identify differentially regulated genes
during this process we performed DNA microarray analysis
with mRNA isolated from cultures at 0, 8, 24 and 48 hours
of EC morphogenesis (Fig. 1). Cy3 and Cy5-labeled cDNAs
were used to probe microarray chips containing 7,075 gene
elements. A total of three chips were hybridized for the time
course analysis by combining Cy5-labeled 0 hour cDNA with
either Cy3 labeled 8 hour, 24 hour, or 48 hour cDNA. Tables
2 and 3 show gene expression differences between different
time points of EC morphogenesis of either upregulated or
downregulated genes, respectively. In both tables, genes are
grouped into functional categories such as growth factors,
ECM-related genes, signaling molecules, EC differentiation
markers, cell cycle and apoptosis regulators and
miscellaneous genes. This data is presented as a ratio of the
difference in fluorescence for each given gene element,
showing changes between experimental versus reference
cDNA (0 hour). The six genes showing the greatest changes
in expression of the more than 7,000 genes assayed are shown
in Tables 2 and 3 and are labeled with an asterisk for each of
the 8, 24 and 48 hours time points. The Notch ligand, Jagged-
1 (Lindsell et al., 1995), was induced 11.1-fold at 8 hours,
the extracellular inorganic phosphate regulator, stanniocalcin
(Olsen et al., 1996), was induced 9.8-fold at 24 hours, and
the angiogenic regulator, angiopoietin-2 (Yancopoulos et al.,
2000), was induced 7.8-fold at 48 hours. By contrast, the
EC-derived mesenchymal cell growth factor, connective
tissue growth factor, CTGF (Grotendorst, 1997), was
downregulated 11.3-fold at 8 hours, the extracellular matrix
gene, fibulin-3 (Giltay et al., 1999), was downregulated
27.2-fold at 24 hours, and a member of the regulator of G-
protein signaling family, RGS5 (Seki et al., 1998), was
downregulated 34-fold at 48 hours. 
Based on the sampling of the genes represented in the
microarray and additional gene expression data, the
differentially regulated mRNAs appeared to fall primarily
into one of five general patterns of gene expression (Fig. 2).
These patterns of gene expression were confirmed for
selected genes using semiquantitative RT-PCR (Fig. 3A),
northern blot (Fig. 3B) and western blot analyses (Fig. 4).
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Fig. 1. Capillary morphogenesis in 3D collagen matrices. Human
ECs were suspended in 3D collagen matrices and, at varying times of
cultures, were fixed, stained with toluidine blue and photographed.
Some cultures were embedded in plastic and thin sectioned to obtain
cross-sectional views of the capillary tubes. Times of the analysis are
indicated. Arrowheads show ECs with intracellular vacuoles and
arrows indicate an EC-lined capillary tube. Bar, 50 m m (8 hour
panel); bar, 50 m m (120 hours panel).
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Patterns A-E illustrate observed trends in gene expression
(Fig. 2A-E). Genes showing these patterns are listed to the
right and become grouped into expression patterns, which
may reflect functional importance at different stages of EC
morphogenesis.
Induction and role of basement membrane matrix
and integrin genes during endothelial cell
morphogenesis in 3D collagen matrices 
It is interesting that a series of genes related to basement
membrane synthesis and assembly are induced (pattern C),
including the collagen type IV a 1 and laminin g 1 chains. These
inductions were confirmed at the protein level by marked
induction of collagen type IV and laminin synthesis and
secretion during morphogenesis (Fig. 4A,C). In addition,
collagen type IV deposits extracellularly around developing
capillary tubes (Fig. 4B). Also induced is the a 1 integrin
subunit, which forms a heterodimer, a 1b 1, with affinity for
both type IV collagen and laminin (Senger et al., 1997). The
a 2 integrin subunit, which forms the heterodimer, a 2b 1, is
markedly upregulated (pattern B) and may similarly contribute
to the appropriate assembly of basement membrane matrix.
Blocking antibodies to the a 2 integrin subunit, but not control
blocking antibodies to the a 5 integrin subunit, cause complete
collapse of pre-existing tubes in the 3D collagen matrix
environment (Davis et al., 2001), suggesting a crucial role for
a 2b 1 in the maintenance of forming capillary tubes. We have
previously shown that a 2b 1 is required for the initiation of
lumen formation through EC intracellular vacuole formation
and coalescence in 3D collagen matrices (Davis and Camarillo,
1996). 
We have expanded this list of genes by performing
differential expression analysis of an additional set of
extracellular matrix and integrin genes (Fig. 5). As shown in
Fig. 5, the RT-PCR data supports the gene array data showing
inductions of the collagen type IV a 1 chain, laminin g 1 and
the a 2 and a 1 integrin subunits. Some of the genes examined
show stable expression throughout the time course, whereas
others are differentially expressed. Such differentially
expressed genes include the laminin a 4 subunit,
Reference
sample Experimental sample
Gene category 0 hour 8 hour 24 hour 48 hour
Growth factors/hormones, 
receptors/modulators
Jagged-1* 1 11.1* 5.6 - 1.1
Angiopoietin-2* 1 1.3 3.4 7.8*
Stanniocalcin* 1 9.2 9.8* 4.0
Placental growth factor 1 3.1 2.4 2.9
Melanin concentrating 1 2.5 1.4 1.0 
hormone
PDGF-b 1 3.7 3.1 2.8
IGF-2 1 1.5 1.8 2.6
Midkine 1 1.2 2.2 1.5
Sprouty 1 1.4 2.0 3.4
Flt-1 (VEGF-R1) 1 1.8 1.5 2.0
Eph A1 1 1.8 1.5 1.1
Eph A7 1 1.4 1.6 1.5
ECM/ ECM receptors, 
cytoskeleton
Collagen type IV, a 1 chain 1 2.3 3.6 4.0
Laminin, g 1 chain 1 1.9 2.3 1.7
Laminin, a 4 chain 1 1.2 1.6 1.6
Heparan sulfate N-deacetylase 1 2.0 2.3 2.5
N-sulfotransferase I
Chondroitin sulfate/keratan 1 1.1 1.3 3.2
sulfate sulfotransferase 
Lysyl oxidase 1 - 1.5 1.0 3.7
Lysyl hydroxylase 1 1.2 1.3 1.9
a 1 integrin subunit 1 1.8 2.1 2.4
a 2 integrin subunit 1 4.6 3.0 1.1
a v integrin subunit 1 2.5 1.1 1.1
GARP 1 3.9 3.1 1.9
ICAM-1 1 4.1 1.7 1.0
Podocalyxin 1 3.0 1.5 1.5
Myosin IC 1 1.7 3.1 3.1
Myosin VI 1 1.3 1.7 2.3
Gelsolin 1 1.1 1.5 2.2
WASP-interacting protein 1 1.4 1.4 1.9
RhoGAP-5 1 1.9 1.8 2.4
Diaphanous 2 1 1.5 1.9 2.6
Coronin 2B 1 1.9 2.1 1.6
Coronin 2A 1 1.8 1.3 1.3
Reference
sample Experimental sample
Gene category 0 hour 8 hour 24 hour 48 hour
Proteinase inhibitors
Alpha-2 macroglobulin 1 1.4 3.1 6.1
Signaling molecules/
transcription factors
Egr-1 1 6.5 4.7 4.7
HLX-1 homeobox gene 1 2.8 3.1 3.4
Gp130 (oncostatin M receptor) 1 2.5 1.7 - 1.1
JAK-1 1 - 1.1 1.2 2.6
JAK binding protein (SOCS-1) 1 3.6 4.1 3.0
IP-3 kinase A 1 2.6 1.6 1.5
Diacylglycerol kinase d 1 2.1 3.0 2.9
RGS-3 1 1.1 1.2 2.0
EC differentiation markers
Angiotensin converting enzyme 1 1.3 1.7 2.6
Von Willebrand Factor 1 1.1 1.3 2.0
Thrombomodulin 1 1.0 1.4 1.9
Protein S 1 - 1.1 1.3 2.2
CD39 1 1.0 3.1 7.2
Cell cycle/apoptosis regulators
Cdc 14 1 1.7 2.0 3.1
Bcl-2 1 1.3 1.6 2.0
A20 zinc-finger protein 1 2.6 1.9 1.8
Pim-1 1 1.5 2.8 1.6 
Miscellaneous
KIAA0212 1 2.3 3.6 4.0
KIAA0758 1 1.0 2.4 5.5
FLJ 20641 1 2.5 1.4 1.0
Ox-2 antigen 1 3.3 2.5 1.9
CD26 1 1.8 2.9 2.9
Sodium bicarbonate 1 3.9 4.2 2.4
cotransporter-2
HMG CoA reductase 1 1.2 1.8 3.0
Mevalonate (diphospho) 1 1.0 1.4 2.0
decarboxylase
Mevalonate kinase 1 1.5 1.5 1.6
Farnesyl-diphosphate 1 1.5 1.5 2.4
farnesyltransferase-1
Table 2. Upregulation of distinct classes of genes during capillary morphogenesis in 3D collagen matrices as determined
by DNA microarray analysis
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thrombospondin-2, and a v integrin subunit, which are
upregulated while the b 3 integrin subunit, thrombospondin-1
and the interstitial matrix protein, fibronectin are
downregulated. Interestingly, differential expression was
observed for the a 1, a 2, a v and b 3 integrin subunits which are
known to regulate angiogenesis in vivo (Brooks et al., 1994;
Senger et al., 1997). The laminin a 5 chain was expressed in a
stable fashion but we have detected little or no expression of
the laminin a 1 chain (not shown) during morphogenesis. This
suggests that two laminin isoforms, laminin-8 ( a 4, b 1, g 1) and
laminin-10 (a 5, b 1, g 1), are particularly relevant during this
process. Recent studies support this conclusion showing a role
for the laminin-8 and -10 isoforms in endothelial cell function
(Miner et al., 1998; Lefebvre et al., 1999; Kortesmaa et al.,
2000). 
Other induced genes involved in basement membrane
matrix assembly are heparan sulfate deacetylase/
sulfotransferase (i.e. an enzyme that regulates the rate-
limiting step in heparan sulfate synthesis) (Kakuta et al.,
1999), lysyl oxidase, lysyl hydroxylase, a 2-macroglobulin
and melanoma-associated antigen (Table 2; Fig. 3; Fig. 4).
Lysyl oxidase and lysyl hydroxylase contribute to matrix
stability through protein-protein crosslinking (Uzawa et al.,
1999), whereas a 2-macroglobulin is a broad-spectrum
proteinase inhibitor with growth factor binding domains
(Jensen, 1989; Borth, 1992; Gonias et al., 2000). a 2-
macroglobulin may contribute to ECM stability by inhibiting
proteolysis and/or regulate EC morphogenesis by controlling
growth factor availability. It is markedly induced both at the
level of mRNA (Fig. 3A) and protein (Fig. 4C). As shown in
Fig. 4C, two induced a 2-macroglobulin bands are observed,
which represent the intact protein (upper band) and a
proteolytically cleaved form (lower band) that is consistent
with proteolytic cleavage in its bait region (Jensen, 1989;
Borth, 1992). Previously, we have observed marked
inductions of matrix metalloproteinase 1 (MMP-1), MMP-9,
MT1-MMP, and uPA during EC morphogenesis (Davis et al.,
2001) that may account for this a 2-macroglobulin cleavage.
Melanoma-associated antigen is a putative extracellular
matrix protein with an RGD sequence and peroxidase-like
domains (Mitchell et al., 2000) (Fig. 3B). A highly
homologous Drosophila protein named peroxidasin contains
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Reference
sample Experimental sample
Gene category 0 hour 8 hour 24 hour 48 hour
Growth factors/hormones, 
receptors/modulators
Connective tissue growth 1 - 11.3* - 8.9 - 5.9
factor (CTGF)*
Cyr61 1 - 3.9 - 1.5 1.0
Bone morphogenetic protein-6 1 - 2.3 - 3.0 - 3.3
Frizzled related protein-1 1 - 1.6 - 2.6 - 3.2
Eph B4 1 - 1.3 - 1.4 - 1.5
Eph B1 1 - 1.1 - 1.4 - 1.5
Ephrin A1 1 - 1.7 - 1.9 - 1.3
ILGFBP-7/angiomodulin 1 - 2.6 - 4.4 - 3.9
Signaling molecules/
transcription factors
RGS-5* 1 - 2.6 - 13.9 - 34.0*
RGS-4 1 - 5.4 - 7.5 - 7.8
RGS-2 1 - 2.0 - 2.9 - 3.2
Transglutaminase-2 (Gh) 1 - 4.4 - 10.3 - 9.5
Axl receptor tyrosine kinase 1 - 1.7 - 2.1 - 2.9
Id-1 1 - 9.3 - 8.6 - 9.8
Id-2 1 - 2.1 - 2.5 - 2.9
Id-3 1 - 5.0 - 4.5 - 6.0
HES-1 1 - 4.1 - 3.6 - 2.7
Coup-TFII 1 - 2.4 - 2.5 - 3.0
ECM/ECM receptors,
cytoskeleton
Fibulin-3 (S1-5 protein)* 1 - 5.4 - 27.2* - 24.7
Thrombospondin-1 1 - 1.8 - 2.4 - 1.5
Collagen type XIII 1 - 2.6 - 3.2 - 3.5
b 3 integrin subunit 1 1.0 - 1.8 - 4.4
ICAM-2 1 - 5.0 - 3.9 - 2.1
CD44 1 - 1.5 - 2.6 - 3.2
RHAMM 1 1.0 - 1.1 - 2.5
Syntenin 1 - 2.3 - 4.6 - 5.6
Multimerin 1 - 1.7 - 2.4 - 2.2
Proteinase inhibitors
PAI-1 1 2.1 - 2.3 - 6.6
PAI-2 1 1.1 - 2.3 - 3.7
Reference
sample Experimental sample
Gene category 0 hour 8 hour 24 hour 48 hour
EC differentiation markers
Endothelin-1 1 - 10.3 - 5.6 - 2.0
Cell cycle/apoptosis regulators
Cdc2 (Cdk1) 1 - 2.8 - 3.4 - 3.5
Cdc20 1 - 2.1 - 2.3 - 3.0
Cdc25B 1 - 1.8 - 2.2 - 2.2
Cdc46 (mcm5) 1 - 1.9 - 2.1 - 1.6
Mcm2 (mitotin) 1 - 2.6 - 3.1 - 3.5
Mad-2 1 - 1.5 - 2.1 - 2.4
Cyclin A1 1 - 2.4 - 2.8 - 4.2
Cyclin B2 1 - 2.2 - 2.5 - 2.2
PRC-1 1 - 1.6 - 2.1 - 2.3
Replication protein A1 1 - 1.7 - 2.2 - 2.8
Proliferation assoc. 2G4 1 - 1.7 - 1.6 - 2.3
PCNA 1 - 1.7 - 2.1 - 1.6
Thymidylate synthetase 1 - 3.9 - 5.1 - 3.2
Kinesin-like 4 (Kid) 1 - 1.4 - 1.8 - 2.2
Kinesin-like 5 1 - 1.9 - 2.5 - 2.4
Ran 1 - 2.2 - 2.3 - 2.5
Ran-binding protein-1 1 - 1.8 - 2.0 - 2.1
Caspase-4 1 - 2.0 - 3.1 - 2.8
Proteasome subunit, a -1 1 - 2.4 - 2.2 - 2.8
Proteasome subunit, b -1 1 - 2.2 - 2.2 - 2.2
Proteasome subunit, b -3 1 - 1.6 - 1.8 - 1.9
Proteasome subunit, b -4 1 - 1.5 - 1.6 - 2.3
Proteasome subunit, b -7 1 - 1.9 - 2.5 - 2.5
Proteasome 26S, non-ATPase 1 - 1.6 - 2.0 - 1.8
subunit 11
Proteasome 26S, non-ATPase 1 - 1.6 - 1.5 - 1.8
subunit 4
Ubiquitin B 1 - 1.7 - 2.2 - 1.4
Ubiquitin C 1 - 1.8 - 2.6 - 1.6
Ubiquitin C-terminal esterase L1 1 - 2.1 - 3.3 - 3.0
Miscellaneous
Pentaxin 1 - 8.2 - 10.8 - 15.2
Flotillin-1 1 - 2.7 - 2.1 - 3.0
VAMP-5 (myobrevin) 1 - 2.1 - 2.3 - 2.7
Annexin A1 1 - 5.2 - 4.1 - 1.9
Table 3. Downregulation of distinct classes of genes during capillary morphogenesis in 3D collagen matrices as
determined by DNA microarray analysis
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peroxidase and extracellular matrix motifs and has been
found to incorporate into basement membranes (Nelson et al.,
1994). Overall, these data indicate that ECs are synthesizing
basement membrane components such as collagen type IV,
laminin and heparan sulfate for the purpose of differentiation
during morphogenesis. By contrast, other ECM proteins such
as fibronectin, which are more typically expressed by
mesenchymal cells, are downregulated. 
A.
Stanniocalcin p16/INK4a Sodium bicarbonate cotransporter 2 Diacylglycerol kinase d Pim-1
Midkine Laminin a 4 Flt-1 (VEGF-R1) IP-3 kinase A
PDGF-b PlGF Heparan sulfate N-deacetylase/N-sulfotransferase I
Rho GAP-5 KIAA0212 SOCS-1 A20
B.
Jagged-1 a 2 Integrin Melanin concentrating  hormone TFPI-2
ICAM-1 a V Integrin Egr-1
GARP Podocalyxin CMG-2
C.
Sprouty ACE Angiopoietin-2 von Willebrand Factor RGS3 HMG CoA reductase NADH-ubiquinone
Cdc14 CD39 Lysyl oxidase CMG-3 GCPKRK-1 Chondroitin 6/keratan sulfate oxidoreductase,B12
IGF-2 Gelsolin Collagen IV a 1 chain a 1 Integrin a 2 Macroglobulin sulfotransferase I Mevalonate decarboxylase
Bcl-2 Myosin IC Laminin g 1 Lysyl hydroxylase Thrombomodulin Protein S Melanoma-associated
antigen
D.
Id-1 CMG-4 Cdk1 (Cdc2) b 3 Integrin RGS5 Transglutaminase-2 Prothymosin a Proteasome, a -1
Id-2 PAI-2 Cyclin A1 Collagen XIII RGS4 Ran Fte-1 Proteasome, b -7
Id-3 RHAMM Cyclin B2 Syntenin RGS2 Ran-binding protein 1 Mcm-2
Coup-TF II CD44 BMP 6 Pentaxin Caspase 4 Frizzled-related protein 1 Mad-2
E.
Annexin A1 Caveolin-1 CMG-1 HES-1





















Fig. 2. Patterns of gene expression observed during capillary morphogenesis in 3D collagen matrices. Five different major patterns of gene
expression were observed in this system, indicated as patterns A-E. Genes, whose expression patterns most closely fit these patterns, are
indicated next to each pattern.
Fig. 3. Differential expression of genes during capillary morphogenesis as
determined by reverse transcriptase-PCR and northern blot analyses. Total RNA was
prepared from EC cultures at 0, 8, 24 and 48 hours of culture. The RNA was reverse
transcribed and PCR was performed using gene-specific primer sets (left panel).
Control G3PDH is shown to indicate its stable expression and that equal loading
occurred throughout the lanes. Selected genes were analyzed for expression using
northern blot analysis (right panel). 3 m g of total RNA was loaded per lane for each
time point and blots were probed with 32P-labelled cDNAs. In the upper panels, the
upper arrow indicates the position of the 28S rRNA subunit, whereas the lower arrow
indicates the position of the 18S rRNA subunit. The lower panels show just the area
of the blot with the hybridizing band. The G3PDH blot indicates equal loading of
RNA and stable expression of G3PDH mRNA during the time course.
2762
Blockade of collagen type IV synthesis interferes
with endothelial cell morphogenesis in 3D collagen
matrices
To address a potential functional role for collagen type IV in
EC morphogenesis, cultures were treated with ethyl 3,4-
dihydroxybenzoate (edb), a prolyl hydroxylase inhibitor that
blocks collagen synthesis (Sasaki et al., 1987; Nandan et al.,
1990). As shown in Fig. 6A and B, blockade of collagen
type IV induction prevents progression of tube formation.
Furthermore, edb blocks collagen type IV synthesis during
capillary morphogenesis (Fig. 6C). Providing support for our
findings are previous studies showing that blockade of collagen
or basement membrane synthesis can interfere with angiogenic
responses (Ingber and Folkman, 1988; Maragoudakis et al.,
1988; Iruela-Arispe et al., 1991; Sephel et al., 1996). The
addition of edb to proliferating ECs at the doses used in the
above experiment on plastic substrates had no toxic effect and
previous investigators have shown no toxic effect of edb on
different cell types (Nandan et al., 1990). These data show that
collagen type IV synthesis, which is upregulated by increases
in the a 1 collagen IV subunit mRNA, appears to be necessary
for capillary tube formation in collagen matrices. We are
unable to rule out the possibility that other triple-helical
collagens are involved in morphogenesis, since edb can block
the synthesis of other collagen types as well.
Upregulation of cytoskeletal proteins during
endothelial cell morphogenesis in 3D collagen
matrices
Additional upregulated genes (pattern C) include cytoskeletal
and cytoskeletal regulatory proteins that mediate ECM-
mediated signalling pathways. These are myosin IC (Swanson
et al., 1999), myosin VI, diaphanous-2, WASP-interacting
protein (WIP), gelsolin and RhoGAP-5. WIP is known to bind
the actin regulatory protein, profilin (Anton et al., 1998), a gene
that shows a similar expression pattern (Salazar et al., 1999).
We have previously reported that gelsolin, VASP and profilin
are coordinately upregulated during capillary morphogenesis
(Salazar et al., 1999). It is interesting that upregulation of
myosin IC as well as coronins 2A and 2B (Table 2) occur
during EC morphogenesis since they have been observed
associated with phagosome membranes (Morrissette et al.,
1999; Swanson et al., 1999). We have previously suggested that
phagosomes show similarities with the intracellular vacuole
compartment that controls EC lumen formation (Davis and
Camarillo, 1996; Bayless et al., 2000).
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Fig. 4. Differential gene expression during capillary morphogenesis as determined by western blot analysis and immunohistochemistry. EC-
collagen gel extracts or conditioned medium were prepared or collected at the indicated time points. Samples were run on SDS-PAGE and, after
blotting, were probed with antibodies directed to various proteins. Cell extracts were probed with antibodies directed to collagen type IV, a 2-
macroglobulin and Id-1. Conditioned medium samples were probed with antibodies directed to collagen type IV or laminin. The arrows in the
collagen type IV blots represent the a 1 and a 2 chains of collagen type IV. Arrows indicate the position of molecular weight markers on the
blots. In B, a 48 hour culture was stained with antibodies to collagen type IV under non-permeabilizing conditions. No staining was observed
without the addition of the primary anti-collagen type IV antibody. Bar, 50 m m.
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Induction of genes associated with
endothelial cell differentiation and
cholesterol biosynthesis occur during
endothelial cell morphogenesis in 3D
collagen matrices 
In addition to the induction of ECM-
or cytoskeleton-related genes, there is
interesting evidence that EC differentiation
genes are upregulated (Table 2). Induced
EC differentiation markers include von
Willebrand factor, angiotensin converting
enzyme (ACE), thrombomodulin, protein S
and CD39 (an EC cell surface ecto
ATP/ADPase) (Saijonmaa et al., 2000;
Goepert et al., 2000). These data suggest that
phenotypic changes are occurring with
increasing expression of EC-specific genes.
Other induced genes include HMG CoA
reductase, mevalonate decarboxylase, and
mevalonate kinase, which are genes
associated with cholesterol biosynthesis
(Olivier and Krisans, 2000). Interestingly,
these three enzymes have recently been
found to associate with peroxisomes (Olivier
and Krisans, 2000). In addition, CD26, a
dipeptidyl peptidase that regulates hormone
and chemokine activities, is also upregulated
(Mentlein, 1999). Additional induced genes
(pattern B) include ICAM-1, GARP (Ollendorff et al., 1994),
jagged-1 (Lindsell et al., 1995), melanin concentrating
hormone (also identified by differential display) (Hawes et al.,
2000), the transcription factor, egr-1 (Silvermann and Collins,
1999) and the proteinase inhibitor, tissue factor pathway
inhibitor-2 (TFPI-2) (Rao et al., 1996) (Table 2; Fig. 3).
Regulated expression of growth factors, hormones
and genes regulating the JAK-STAT pathway during
endothelial cell morphogenesis in 3D collagen
matrices 
A series of hormones and growth factors are induced (pattern
A) such as stanniocalcin, PDGF-b, placental growth factor
(PlGF) (Carmeliet and Jain, 2000; Conway et al., 2001) and
midkine, which suggests that ECs produce a series of autocrine
factors during morphogenic events. Interestingly, a VEGF
receptor with affinity for PlGF, VEGF-R1 (Park et al., 1994),
is upregulated along with PlGF. In addition, signalling
molecules in the JAK-STAT pathway are induced including the
common gp130 subunit of a number of growth factor receptors
(e.g. oncostatin M, leukemia inhibitory factor, IL-6 receptors)
(Funamoto et al., 2000; Imada and Leonard, 2000). Oncostatin
M and leukemia inhibitory factor have been reported to inhibit
EC proliferation (Takashima and Klagsbrun, 1996). In
addition, JAK-1 and the JAK-1 inhibitor, SOCS-1 are induced
(Krebs and Hilton, 2000) (Table 2). Interestingly, three genes
whose transcription is dependent on this pathway, a 2-
macroglobulin, protein S and angiotensin-converting enzyme,
are upregulated along with these genes, suggesting a functional
upregulation of the JAK-STAT signal transduction pathway
(Hooper et al., 1997; Zhang et al., 1999b; Saijonmaa et al.,
2000). In addition, the anti-apoptotic gene, Pim-1, which is a
downstream target of STAT3 following gp130 receptor ligation
(Shirogane et al., 1999), is upregulated (Table 2). Two other
anti-apoptotic genes, bcl2 (Nor et al., 1999) and A20 (Lee et
al., 2000), were upregulated along with Pim-1 (Table 2),
whereas a proapoptotic gene, Nip2, was downregulated
(Brusadelli et al., 2000) (Table 4).
Sprouty, a negative regulator of FGF-signalling and
tyrosine kinase receptors, is upregulated during
endothelial cell morphogenesis in 3D collagen
matrices
Further upregulated genes include receptor tyrosine kinase
Fig. 5. Differential expression of extracellular
matrix and integrin genes during capillary
morphogenesis. RT-PCR was performed to assess
the mRNA expression patterns of various
extracellular matrix proteins (A) and integrin
subunits (B) over a 48 hour time course. Total
RNA was prepared from EC cultures at 0, 8, 24
and 48 hours of culture. The RNA was reverse
transcribed for RT-PCR and PCR was performed
using gene specific primer sets.
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ligands or regulators of tyrosine kinases such as sprouty,
angiopoietin-2, and IGF-2 (Pattern C). Interestingly, sprouty
has previously been reported to inhibit FGF-mediated
signalling as well as other receptor tyrosine kinase-mediated
pathways (Reich et al., 1999; Wong et al., 2000) and is
important in the regulation of EC and epithelial branching
morphogenesis (Hacohen et al., 1998; Metzger and Krasnow,
1999; Lee et al., 2001). In support of this finding is the
observation that the FGF-2 gene is markedly downregulated
(Fig. 3A) as well as syntenin (Table 3), a cytoplasmic regulator
of the FGF-binding cell surface heparan sulfate proteoglycan,
syndecan (Grootjans et al., 1997). These data suggest that
FGF-2-mediated signaling pathways are downregulated during
EC morphogenesis. Another notable downregulated growth
factor related gene is frizzled-related protein-1, which is a
Wnt antagonist protein (Rattner et al., 1997). Genes that are
known to be constitutively or heavily expressed by ECs such
as caveolin-1, endothelin-1, ICAM-2, CTGF and Cyr61 are
downregulated at the 8 hour time point, and then return to
baseline or near baseline expression by 48 hours (pattern E).
Marked downregulation of Id and RGS family genes
during endothelial cell morphogenesis in 3D
collagen matrices
Additional downregulated genes (pattern D) include Id-1, 2 or
3, which are inhibitory transcription factors of the helix-loop-
helix family (Norton, 2000). Recently, knockout mice with
combined defects in Id-1 and Id-3 were shown to have a
defect in tumor angiogenesis (Lyden et al., 1999). Other
downregulated genes include RGS5, RGS4 and RGS2, which
are members of the regulator of G-protein signalling (RGS)
family (Druey et al., 1996; DeVries et al., 2000) that inhibit G-
protein signalling through GTPase activating activity.
Transglutaminase 2, which is also referred to as G-protein Gh,
is also downregulated (Vezza et al., 1999; Zhang et al., 1999a).
Downregulation of RGS genes suggests that activation of G-
protein signaling pathways may be occurring. Interestingly,
this downregulation occurs during a period of extensive
branching morphogenesis in our system (Fig. 1) and RGS
proteins are known to block cell migration by inhibiting G-
protein-linked chemoattractant receptors (Bowman et al.,
1998). Interestingly, a farnesyl transferase enzyme that
participates in the functional activation of G-proteins by
stimulating membrane targeting is induced during the time
course (Dietrich et al., 1996) (Table 2).
Marked downregulation of cell cycle and ubiquitin-
proteasome genes during endothelial cell
morphogenesis in 3D collagen matrices
An interesting observation in the array analysis is that a large
series of genes associated with cell cycle regulation show
expression changes. A series of genes known to play a positive
role in cell cycle progression such as cyclin B2, cdc2, cyclin
A1, cdc20, cdc25B, cdc46, mcm2, mad2, PRC-1, PCNA, ran,
thymidylate synthetase, transglutaminase-2 (Gh) and the Id
genes are downregulated (Nurse et al., 1998; Jiang et al., 1998;
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Fig. 6. Interference with collagen type IV synthesis and secretion
blocks capillary morphogenesis in 3D collagen matrices. EC cultures
were treated with or without ethyl 3,4-dihydroxybenzoate (edb), an
inhibitor of prolyl hydoxylase. Cultures were fixed at varying times,
stained, quantitated for lumen formation (B) and photographed (A).
Bar, 50 m m (A). Cell extract samples (from cultures with or without
edb at 300 m M) and at different times of culture were collected and
run on 7% SDS-PAGE gels (C). Lanes 1 and 2, 0 hours; lanes 3,4, 8
hours; lanes 5,6, 24 hours; lanes 7,8, 48 hours; lanes 9,10, 72 hours.
Proteins were blotted to PVDF membranes and were probed with
antibodies to collagen type IV. Arrows indicate the position of the a 1
and a 2 chains of collagen type IV.
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Tye, 1999; Heald and Weis, 2000; Howell et al., 2000; Norton,
2000; Nilsson and Hoffmann, 2000; Rudner and Murray, 2000;
Nigg, 2001) (Table 3). In addition, a large number of genes
associated with ubiquitin-mediated protein degradation
through proteasomes are downregulated, which is consistent
with this inhibition of the cell cycle (Bounpheng et al., 1999;
Koepp et al., 1999; Page and Hieter, 1999) (Table 2). These
data strongly support the concept that inhibition of cell cycle
progression of ECs is occurring. It is interesting that many of
the genes regulate the G2-M checkpoint of the cell cycle by
regulating the function of the cdc2/cyclin B complex (Nurse et
al., 1998; Nigg, 2001). In support of this conclusion is the
additional finding that a cell cycle inhibitor, cdc14, a
phosphatase that inactivates cdc2 kinase (Vistin et al., 1998),
is upregulated (Table 2). Also, the cell cycle inhibitor,
p16/INK4, which inhibits cyclin dependent kinase 4 (Serrano
et al., 1993), is upregulated (Fig. 3A). 
Isolation and identification of novel capillary
morphogenesis genes (CMGs) by differential display
and cDNA library screening
Novel genes, whose messages were differentially regulated
during EC morphogenesis, were isolated using differential
display and cDNA library screening. We have termed the novel
genes identified by these techniques, capillary morphogenesis
genes (CMGs), which are defined as novel genes that are
differentially expressed during the process of EC
morphogenesis. A partial list of the genes identified by this
analysis are shown in Table 4 with expression patterns,
sequence identities and functional significance, if known. A
number of known differentially regulated genes were identified
in this analysis including melanoma-associated antigen, TFPI-
2, germinal center protein kinase related kinase, melanin
concentrating hormone, prothymosin-a , NADH-ubiquinone
oxidoreductase-B12 subunit, sodium bicarbonate
cotransporter-3 (Pushkin et al., 1999), NIP-2 (Brusadelli et al.,
2000) and Fte-1. Known functions for these genes are listed in
Table 4. Melanoma-associated antigen (MG50) (Mitchell
et al., 2000) is markedly upregulated (pattern C) during
morphogenesis, whereas the plasmin and serine proteinase
inhibitor, TFPI-2, is strongly upregulated early in the time
course (pattern B). Interestingly, melanin concentrating
hormone and another member of the sodium bicarbonate
cotransporter family (cotransporter-2 versus cotransporter-3)
were identified as being differentially regulated by DNA
microarray analysis. 
To confirm the expression patterns for genes isolated by
differential display analysis, RT-PCR, northern blot and
western blot analyses were performed (Fig. 7). These results
show that the CMGs and other genes are differentially
expressed during EC morphogenesis. Note that we have
currently identified the full length sequence of four novel
genes, CMG-1, CMG-2, CMG-3 and CMG-4 and have small
cDNA fragments of two additional genes (CMG-5 and CMG-
6) that currently do not match the GenBank databases. The full-
length sequences of CMG-3 and CMG-4 will be published
elsewhere (A.M. et al., unpublished). 
A novel differentially expressed capillary
morphogenesis gene, CMG-1, contains coiled-coil
domains and targets to an intracellular vesicular
compartment
Here, we present the full-length sequence of CMG-1, which
encodes a putative intracellular 65 kDa protein. The sequence
shown in Fig. 8A reveals a series of coiled-coil domains
(from residues 96 to 560) that, in other proteins, have been
reported to participate in protein-protein binding, protein
multimerization, vesicular fusion and other functions
(Burkhard et al., 2001). CMG-1 also contains several
consensus motifs for phosphorylation including two for
tyrosine phosphorylation at residues 96/97 and 572, one for
cAMP/cGMP protein kinases at residue 260, and multiple
protein kinase C and casein kinase II sites. Homology
searches revealed the greatest similarity (24% identity, 46%
positives from residues 9-591) with a putative C. elegans
protein, C18H9.8. It also shows 24% identity from residues
104-592 (in the coiled coil domain) with myosin heavy chain
sequences from various species. The sequence also matches
human genome sequences and maps to human chromosome
9q. Interestingly, the pattern of CMG-1 gene expression
(pattern E) during EC morphogenesis mirrors that of
caveolin, and other major EC genes (Figs 2, 3). Both genes
show a marked downregulation at 8 hours of morphogenesis
followed by a return to baseline by 48 hours. To examine the
Table 4. Differentially regulated genes identified by differential display and cDNA library screening
Expression pattern
Gene name 0 h 8 h 24 h 48 h Gene function
CMG-1 +++ + ++ +++ Novel, 65 kDa, unknown, vesicular compartment
CMG-2 + +++ ++ + Novel, 45 kDa, unknown, endoplasmic reticulum, LM, CIV-binding
CMG-3 + + ++ + Novel, unknown, alternatively-spliced forms
CMG-4 +++ ++ + - Novel, unknown, nuclear localization
CMG-5 +/- +++ + +/- Novel, unknown, 328 bp fragment
CMG-6 +/- +++ + +/- Novel, unknown, 198 bp fragment
Melanoma-associated antigen (MG50) + + ++ +++ Extracellular matrix-like protein with RGD site/peroxidase-like domains
Tissue factor pathway inhibitor-2 + +++ ++ + Extracellular matrix-associated serine proteinase inhibitor
Germinal center protein kinase-related +/- + + +++ In gene family of proteins with functions in MAP kinase, Rho GTPase 
kinase-1 family signalling
Melanin-concentrating hormone + +++ ++ + Regulates ion/water transport across membranes
Sodium bicarbonate cotransporter-3 +/- + ++ + Regulates intracellular/extracellular pH
Prothymosin-a +++ + - - Nuclear protein, implicated in cell proliferation
NADH ubiquinone oxidoreductase, +/ - + + +++ Enzyme in electron-transport chain
B12 subunit
NIP-2 +++ ++ + +/- bcl2-interacting protein
Fte-1 +++ + +/- - v-fos transformation effector gene
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expression pattern of CMG-1 in adult versus fetal human
tissues, RT-PCR was performed (Fig. 8C). As shown in Fig.
8, the strongest expression was observed from adult and fetal
kidney cDNAs with detectable expression in adult heart,
placenta, lung, liver and pancreas. Minimal to no expression
was observed in the adult brain or skeletal muscle cDNA
samples. Detectable expression was observed in fetal skeletal
muscle as well as fetal heart, lung and liver, while minimal
to no expression was observed from fetal brain, thymus and
spleen cDNAs. 
To reveal possible functions for CMG-1, a CMG-1-green
fluorescent protein (GFP) chimera was constructed to assess
where the protein targets intracellularly. Transfection of 293
epithelial tumor cells revealed targeting of the CMG-1 fusion
protein to an intracellular vesicular compartment (Fig. 9A-
C). To accomplish this experiment in human ECs, a
recombinant adenovirus was constructed in the pAdEasy
system carrying the CMG-1-GFP fusion protein. Infection of
ECs resulted in an apparent intracellular distribution identical
to that observed in 293 cells with targeting to multiple
intracellular vesicles (data not shown). By contrast, control
GFP distributes throughout 293 cells or ECs with a
cytoplasmic staining pattern (Fig. 9D). Coimmunostaining of
ECs expressing CMG-1-GFP by using antibodies to various
known intracellular compartments such as endosomes,
Weibel-Palade bodies, caveolae, mitochondria, Golgi
apparatus (GM130) and lysosomes failed to reveal any
colocalization. More work is necessary to identify this
intracellular compartment. 
A novel differentially expressed capillary
morphogenesis gene, CMG-2, contains a putative
transmembrane domain, targets to the endoplasmic
reticulum and shows affinity for the basement
membrane matrix proteins, collagen type IV and
laminin 
Here, we also present the full-length sequence of a second
novel gene, CMG-2, which is markedly upregulated at 8 hours
during EC morphogenesis, as revealed by both RT-PCR and
northern blots (Fig. 8B). This gene reveals a putative 45 kDa
protein with a putative transmembrane segment and a potential
signal peptide (residues 1-33) (Fig. 8B). Polyclonal antibodies
directed to recombinant CMG-2 were prepared, affinity
purified and probed on western blots of ECs undergoing
morphogenesis. As shown in Fig. 7C, induced protein bands
migrating at the predicted size of 45 kDa are detected using
this antibody. This antibody also specifically detects CMG-2-
GFP or CMG-2-myc epitope-tagged fusion proteins by
immunoprecipitation or immunoblotting (data not shown),
demonstrating specificity for CMG-2. By contrast, G3PDH or
actin antibodies show stable expression during the time course
(not shown). 
The CMG-2 gene maps to the human genome sequence and
is located on chromosome 4q. Using the PSORT II program,
the protein was predicted to have a 44% probability of targeting
to the endoplasmic reticulum membrane with lesser
probabilities to the Golgi apparatus or plasma membrane.
Proximal to the potential transmembrane segment, homology
searches reveal a von Willebrand Factor A domain (a matrix-
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Fig. 7. Differential expression of novel capillary morphogenesis genes (CMGs) during morphogenesis in 3D collagen matrices. Differential
display and cDNA library screening were used to identify differentially expressed genes during capillary morphogenesis. DNA sequencing
revealed whether genes were known or novel and gene-specific primers were prepared to assess differential expression by RT-PCR (A). RT-
PCR was performed to assess the mRNA expression patterns of various CMGs and known genes over a 48 hour time course. Total RNA was
prepared from EC cultures at 0, 8, 24 and 48 hours of culture. The RNA was reverse transcribed for RT-PCR and PCR was performed using
gene-specific primer sets. In addition, cDNA probes were made in select cases to perform northern blots (B). The far-left panel in B represents a
methylene blue-stained blot indicating the position of the 28S and 18S rRNA bands and showing equal loading of 3 m g of total RNA per lane.
(C) A western blot of cell extracts from a time course of capillary morphogenesis is shown using affinity purified CMG-2 antibodies. MCH,
melanin concentrating hormone; GCPKRK, germinal center protein kinase related kinase-1.
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binding domain) from residues 44-213. In addition, WH-1
block homologies were detected to WASP, a cdc42-binding
protein that regulates the actin cytoskeleton (Anton et al., 1998)
(from residues 250-259 and 315-334). The human tissue
distribution of CMG-2 was assessed by RT-PCR (Fig. 8C). As
shown in Fig. 8C, CMG-2 was detected in placenta but was not
detected in the other adult or fetal tissues examined. 
To address where CMG-2 may target within ECs, the same
approach described above was performed using a recombinant
adenovirus carrying a CMG-2-GFP fusion protein. ECs were
infected revealing that CMG-2-GFP primarily targets to
endoplasmic reticulum (ER) using fluorescence microscopy.
This is shown in a double staining experiment using the ER
protein, Hsp47, which is a chaperone protein for collagens
type I and IV (Fig. 9E-G) (Clarke et al., 1991; Hendershot and
Bulleid, 2000; Nagai et al., 2000). The staining pattern does
not overlap with a Golgi-specific marker (not shown). In
addition, we have observed CMG-2-GFP to be present within
intracellular vesicles in some cells, suggesting that it may be
capable of cycling from the ER to intracellular
vesicles or that it can target to more than one
compartment. We have not yet observed
targeting of CMG-2-GFP to the plasma
membrane. 
A 20 kDa portion of the CMG-2 protein with
sequence homology to the Von Willebrand factor
A domain was expressed in bacteria and tested
for its ability to bind extracellular matrix proteins
(Fig. 10A,B). The recombinantly expressed
protein along with a control GFP recombinant
protein were purified using their histidine tags.
These proteins were adsorbed to plastic and were
incubated with biotinylated collagen type IV,
laminin, fibronectin, osteopontin and control
albumin. As shown in Fig. 10C, the CMG-2
protein but not the control GFP protein showed
strong binding to the basement membrane
proteins, collagen type IV and laminin, but
showed little or no binding affinity for the other
ECM proteins. This data suggests that CMG-2
has affinity for matrix proteins, which implies a
potential role in basement membrane matrix
synthesis or assembly due to its localization
within the endoplasmic reticulum of ECs.
DISCUSSION
DNA microarray analysis of differential gene
expression during human capillary morphogenesis
in 3D collagen matrices
It has been shown that microarray technology has the ability
to accurately represent global changes in gene expression
(Brown and Botstein, 1999). A time course analysis of EC
morphogenesis during tube formation provides information on
potentially important genes that regulate this process. We have
shown that dramatic regulation of many genes occurs as tube
formation progresses. Analysis of gene expression revealed
that jagged-1, stanniocalcin and angiopoietin-2 were the most
induced genes, whereas CTGF, fibulin-3 and RGS-5 were the
most repressed genes at 8, 24 and 48 hours, respectively.
Previously, increased jagged expression was observed during
FGF-2-mediated EC morphogenesis in fibrin matrices and was
reported to inhibit invasion and tube formation, thus
implicating it as a negative regulator of the process (Zimrin et
Fig. 8. Amino acid sequences, domain analyses and
mRNA tissue distribution of two novel differentially
expressed genes, CMG-1 and CMG-2. (A) Amino
acid sequence of CMG-1. Bold letters indicates a
coiled-coil domain structure and underlined letters
indicate potential tyrosine phosphorylation sites. The
nucleotide sequence of CMG-1 has been submitted to
GenBank (accession no. AY040325). (B) Amino acid
sequence of CMG-2. The bold letters proximal to the
transmembrane segment show homology to a von
Willebrand Factor A domain and the putative
transmembrane domain is underlined. The nucleotide
sequence of CMG-2 has been submitted to GenBank
(accession no. AY040326). (C) RT-PCR analysis of
mRNA tissue (adult versus fetal) distribution of
CMG-1 and CMG-2. The tissue distribution of control
G3PDH is also shown.
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al., 1996). A recent study implicated a positive
role for jagged-1 and its receptor, Notch-4 (which
shows a slight mRNA induction in our system) in
EC morphogenesis (Uyttendaele et al., 2000).
Angiopoietin-2 has also been implicated in
angiogenesis in a number of contexts
(Yancopoulos et al., 2000) and has previously
been reported to be produced by ECs (Mandriota
and Pepper, 1998). It has been reported to be an
inhibitor of angiogenesis by competing with
angiopoietin-1 binding to tie-2, a receptor tyrosine
kinase (Yancopoulos et al., 2000). By contrast,
angiopoietin-2 may disrupt stable pericyte-EC
interactions and initiate angiogenesis along with
VEGF (Holash et al., 1999). Stanniocalcin, a
hormone that regulates extracellular inorganic
phosphate concentrations in vivo by affecting
renal tubular reabsorption of phosphate, is known
to be upregulated in some cell types in response to elevations
of extracellular calcium (Olsen et al., 1996). A recent report
identified stanniocalcin as being upregulated during EC
morphogenesis and expressed by in situ hybridization in
tumor-associated blood vessels (Kahn et al., 2000). In addition,
stanniocalcin was found to be upregulated in terminally
differentiated neurons (Zhang et al., 1998) and to protect
neurons from ischemic injury by decreasing the toxicity of
calcium influx through increased influx of phosphate ions
(Zhang et al., 2000). Stanniocalcin may function similarly
during EC morphogenesis to promote survival.
CTGF was originally described as an EC-derived growth
factor for mesenchymal cells and a modulator of fibroblast
ECM production through synergism with TGF- b (Grotendorst,
1997). Recent reports show the production of fibulin-3 by
blood vessels and endothelial cells in vivo (Giltay et al., 1999).
Interestingly, fibulin-3 was reported to bind to a growth factor,
NOVH, which is in a family of growth factors including CTGF
and Cyr61 (Perbal et al., 1999). Marked downregulation (34-
fold) of RGS-5 was observed during the time course. This
gene, as well as two others in the same family, RGS-4 and
RGS-2, were also downregulated. These genes accelerate
GTPase activity of heterotrimeric G proteins, resulting in
inactivation of specific signalling pathways (DeVries et al.,
2000). Downregulation of these genes may indicate that
activation of G protein-mediated pathways may be important
during EC morphogenesis. RGS-5, and -4 have been reported
to interact with Gi family members, whereas RGS-2 and -4 also
interact with Gq (DeVries et al., 2000). By contrast, RGS-3 was
modestly upregulated during the time course and has been
reported to interact with Gi and Gq family members and to
inhibit endothelin-1-mediated signalling (Dulin et al., 1999). 
Differential expression of basement membrane
matrix and integrin genes during EC morphogenesis
in 3D collagen matrices
Our previous work and the work presented here strongly
implicate the ECM- integrin-cytoskeletal axis as being one of
the key regulators of EC morphogenesis in a 3D extracellular
matrix. Previously, we have shown the involvement of
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Fig. 9. Intracellular targeting of CMG-1-GFP and
CMG-2-GFP fusion proteins. CMG-1-GFP and CMG-
2-GFP fusion protein vectors were created by
preparing recombinant adenoviral vectors encoding
the fusion proteins. A control GFP-only virus was also
constructed. Recombinant adenoviruses were infected
into 293 cells (a-d) or endothelial cells (e-g). In a-c,
individual cells were photographed 24 hours after
infection with CMG-1-GFP virus. Arrowheads
represent fluorescent vesicular structures. In d,
individual cells were photographed 24 hours after
infection with GFP only virus. Bar, 20 m m (a-d). In e-
g, endothelial cells were infected with CMG-2-GFP
virus for 24 hours and were fixed and permeabilized
for immunofluorescence staining. Panel e shows cells
expressing the CMG-2-GFP protein. Panel f shows
cells stained with anti-Hsp47 antibodies followed by
staining with rhodamine-conjugated rabbit anti-mouse
antibodies. No background staining was observed by
the addition of the secondary antibodies alone. In g, a
double exposure of the same field photographed in e
and f is shown, illustrating the colocalization of CMG-
2-GFP and Hsp47. Bar, 20 m m (e-g).
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particular integrins in EC morphogenesis and the integrin(s)
involved are dictated by the ECM environment where
morphogenesis occurs (Davis and Camarillo, 1995; Davis and
Camarillo, 1996; Bayless et al., 2000; Davis et al., 2000). In
addition, we have previously shown that actin cytoskeletal
regulatory proteins such as gelsolin, vasodilator-stimulated
phosphoprotein (VASP) and its binding partner, profilin, are
coordinately upregulated during EC morphogenesis (Salazar et
al., 1999). Here, both a 2 and a 1 integrin subunits were
upregulated, and have affinity for basement membrane proteins
such as collagen type IV and laminin. In addition, basement
membrane matrix genes such as collagen type IV a 1 chain,
laminin g 1 chain, laminin a 4 chain and heparan sulfate
deacetylase/sulfotransferase were upregulated. The marked
upregulation of collagen type IV synthesis, which was
observed during EC morphogenesis, appears to play an
important role in these events. Interference with collagen type
IV synthesis blocked EC morphogenesis. Further support of
these conclusions is the identification of a novel gene, CMG-
2, which may participate in these events. It is induced in a
pattern similar to that of a 2b 1 and possesses a von Willebrand
factor-like A domain with affinity for collagen type IV and
laminin. Both collagen type IV and laminin are markedly
induced during EC morphogenesis and deposit around
developing tubes in a time-frame coincident with CMG-2
induction. The colocalization of CMG-2 with Hsp47, a
chaperone for collagen type IV synthesis (Hendershot and
Bulleid, 2000), within the endoplasmic reticulum suggests that
it participates in these events. More work will need to be
performed to investigate the role of CMG-2 in basement
membrane matrix synthesis/assembly and EC morphogenesis. 
Interestingly, melanoma-associated antigen, which is
markedly upregulated during EC morphogenesis in a time-
frame consistent with other basement membrane-related
molecules, may be a basement membrane matrix protein
(Mitchell et al., 2000). It contains ECM-like domains and
strong homology with Drosophila peroxidasin, a protein that
localizes to basement membranes (Nelson et al., 1994). In
addition, within the melanoma antigen protein sequence, is
encoded the complete sequence of IL-1 receptor antagonist,
suggesting that it is the precursor protein for this inhibitor of
IL-1-mediated signalling (Mitchell et al., 2000). Interestingly,
the peroxidase domains of the melanoma antigen protein may
degrade extracellular H2O2 and, along with IL-1 receptor
antagonist protein generation, might facilitate the development
of EC quiescence during the differentiation process (i.e. H2O2
and IL-1 are both EC activators). It is also interesting that
CD39, which degrades ATP and ADP (Goepfert et al., 2000),
and CD26, which can inactivate biologically active peptides
(Mentlein, 1999), are both markedly upregulated in a similar
fashion and might perform similar functions to inhibit EC
activation and stimulate EC quiescence.
A recent study comparing endothelial cell gene expression
from tumor versus normal colonic tissue in vivo also revealed
many changes in extracellular matrix genes (St Croix et al.,
2000). Interestingly, some of the most prominently
differentially regulated genes in tumor endothelium compared
with normal endothelium were the interstitial matrix genes,
collagen type I, a 1 and a 2 chains, collagen type III, a 1 chain
and nidogen, a basement membrane matrix gene. This data
implies that endothelial cells may be undergoing an epithelial-
mesenchymal transition during tumor angiogenesis since the
collagen proteins are more typically synthesized by
mesenchymal cells. By contrast, in our system, the ECs are
inducing the synthesis of basement membrane matrix
molecules such as collagen type IV, laminins and heparan
sulfate, while they are downregulating the synthesis of
interstitial matrix proteins such as fibronectin. 
Novel capillary morphogenesis genes (CMGs) are
differentially expressed during EC morphogenesis
in 3D collagen matrices
One of the clear advantages of our published system (Davis
Fig. 10. Recombinant CMG-2 binds to the basement membrane
matrix proteins, collagen type IV and laminin. The 20 kDa domain
proximal (residues 34-214) to the putative transmembrane domain
was expressed as a histidine-tagged fusion protein in E.coli and
purified by Ni/Cd-sepharose chromatography. Five m g of the protein
was run on a 12% SDS-PAGE gel and was stained by Coomassie blue
(A). A schematic diagram of CMG-2 is shown with the von
Willebrand Factor A domain homology noted from residues 43-212
which is within the 20 kDa recombinantly produced protein (B). A
control protein, histidine-tagged GFP, was similarly purified as a
control. These proteins were adsorbed to plastic at 10 m g/ml and after
blocking with detergent, were incubated with 1 m g/ml of biotinylated
collagen type IV, laminin, osteopontin, fibronectin and human serum
albumin in 0.1% Tween-20 in Tris-buffered saline, pH 7.5. After a 1
hour incubation at 25°C, the wells were washed and then incubated
with 1 m g/ml of avidin-peroxidase in the same Tween-20-Tris buffer
for 30 minutes. The wells were then washed, developed for
peroxidase activity and the plate read in an ELISA plate reader at 490
nm. The values shown are derived from triplicate wells + s.d. (C). 
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and Camarillo, 1996) is its use for the identification of
differentially expressed known and novel genes in capillary
morphogenesis (Salazar et al., 1999; Kahn et al., 2000; Davis
et al., 2001). Other EC morphogenic models have been used to
study differential gene expression (Glienke et al., 2000). Here,
we have used a combination of experimental approaches to
screen large numbers of genes for differential expression
patterns. In addition, we present data showing our initial
characterization of a number of genes that were isolated using
differential display and cDNA library screening (see Table 4
and Fig. 7A). 
Here, we report the full length sequences of CMG-1 and
CMG-2, proteins with coding sequences predicting proteins of
65 kDa and 45 kDa, respectively. CMG-1 is predicted to be
intracellular and to contain a series of coiled-coil domains
involving ~500 amino acids of sequence. A CMG-1-GFP
construct was observed to target to an intracellular vesicular
compartment (Fig. 9A-C). Interestingly, it has an expression
pattern (pattern E; see Figs 2, 7) that mirrors that of caveolin-
1, endothelin-1 and ICAM-2. RT-PCR analysis of tissue
expression reveals its mRNA expression in a number of tissues,
with the most abundant being adult and fetal human kidney
(Fig. 8C). CMG-2 contains a putative transmembrane domain
and signal peptide and was predicted to target to the
endoplasmic reticulum, which was confirmed using a CMG-2-
GFP fusion protein vector (Fig. 9E-G). As discussed above, its
affinity for basement membrane ECM proteins (Fig. 10C)
suggests a potential role in basement membrane matrix
synthesis and assembly in ECs during morphogenesis. CMG-
2 mRNA was detected in placenta and was essentially
undetectable in the other adult and fetal tissues examined (Fig.
8C). Thus, CMG-2 appears to have a much more restricted
tissue distribution than CMG-1. 
Control of EC morphogenesis by differential gene
expression in 3D collagen matrices
The patterns of differential gene expression identified a number
of known positive and negative regulators of angiogenesis
whose differential expression may dictate the molecular
control necessary to form networks of EC-lined tubes. It is
interesting that three genes that have been reported as possible
inhibitors of angiogenic events, angiopoietin-2, jagged-1 and
sprouty (Zimrin et al., 1996; Hanahan, 1997; Yancopoulos,
2000; Lee et al., 2001), were found to be markedly induced
during EC morphogenesis in this system. These genes could
be viewed as negative control genes that suppress specific
pathways during morphogenesis to finely control EC
migration, branching, lumen formation and proliferation.
Alternatively, they may perform stimulatory functions during
EC morphogenesis as is reflected in a recent report concerning
jagged-1 (Uyttendaele et al., 2000)
Overall, the expression changes reported here suggest that
ECs are undergoing major changes during morphogenesis. There
is a clear indication that endogenous basement membrane matrix
synthesis is a prominent event as well as increased expression
of integrins and cytoskeletal regulatory pathways. Upregulation
of EC differentiation markers and genes that may facilitate EC
quiescence are observed. There is marked downregulation of
positive cell cycle regulators and upregulation of negative cell
cycle regulators. In addition, there is upregulation of genes
encoding cytokines, indicating the potential relevance of
autocrine factors in EC morphogenesis. Marked changes in
genes regulating signal transduction cascades are observed
including possible upregulation of G-protein mediated pathways
(via decreased expression of RGS proteins), upregulation of
JAK-STAT pathways, possible downregulation of FGF-mediated
pathways, upregulation of antiapoptotic pathways and
upregulation of cholesterol biosynthetic pathways. These
changes reflect the major regulated gene expression events
during EC morphogenesis in 3D collagen matrices in our
system. Further work will be necessary to compare the gene
expression profiles of ECs under different conditions of
morphogenesis and to assess the role of individual genes during
morphogenic events in vitro and in vivo.
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